Sacituzumab-interferon beta mutein fusion protein - Abion
Alternative Names: Anti TROP2-interferon-beta mutein - AbionLatest Information Update: 12 Jun 2023
At a glance
- Originator Abion
- Class Antineoplastics; Immunotherapies; Interferons; Monoclonal antibodies; Recombinant fusion proteins
- Mechanism of Action Interferon beta replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Urogenital cancer